MeSH term
Frequency | Condition_Probility | Humans | 70 | 0.0 |
Animals | 21 | 0.0 |
Apoptosis | 5 | 0.0 |
Cell Line | 9 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 2 | 0.0 |
Phosphorylation | 18 | 0.0 |
Precipitin Tests | 7 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 5 | 0.0 |
Proto-Oncogene Proteins/biosynthesis/*metabolism | 2 | 9.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 41 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Androstadienes/pharmacology | 3 | 1.0 |
Cell Survival | 6 | 0.0 |
Chromones/pharmacology | 7 | 3.0 |
Enzyme Inhibitors/pharmacology | 9 | 0.0 |
Female | 35 | 0.0 |
Morpholines/pharmacology | 7 | 2.0 |
*Protein-Serine-Threonine Kinases | 22 | 2.0 |
Research Support, Non-U.S. Gov't | 52 | 0.0 |
Transfection | 11 | 0.0 |
Tumor Cells, Cultured | 23 | 0.0 |
Base Sequence | 7 | 0.0 |
Binding Sites | 3 | 0.0 |
Cell Differentiation | 4 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Proto-Oncogene Proteins/*genetics | 4 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Drug Resistance, Neoplasm | 3 | 0.0 |
Protein-Tyrosine Kinase | 2 | 5.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Signal Transduction | 7 | 0.0 |
Gene Amplification | 6 | 0.0 |
Mice | 13 | 0.0 |
Models, Biological | 2 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
*Signal Transduction | 3 | 0.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/metabolism | 3 | 3.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Apoptosis/drug effects | 2 | 0.0 |
Blotting, Western | 11 | 0.0 |
Cell Line, Tumor | 5 | 0.0 |
Cisplatin/*pharmacology | 4 | 3.0 |
Down-Regulation | 3 | 0.0 |
Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Hela Cells | 2 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
*Proto-Oncogenes | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Comparative Study | 7 | 0.0 |
COS Cells | 3 | 0.0 |
Enzyme Activation | 10 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Mutation | 4 | 0.0 |
Protein Transport | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 6 | 2.0 |
Adult | 8 | 0.0 |
Aged | 9 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Male | 11 | 0.0 |
Middle Aged | 8 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Cell Movement | 2 | 0.0 |
Cell Membrane/drug effects/metabolism | 2 | 2.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
Insulin/*pharmacology | 2 | 0.0 |
*Muscle Proteins | 3 | 1.0 |
Mutation/genetics | 2 | 0.0 |
Phosphorylation/drug effects | 3 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 5 | 1.0 |
Rats | 4 | 0.0 |
Signal Transduction/drug effects | 2 | 0.0 |
DNA, Recombinant | 2 | 1.0 |
Neoplasm Invasiveness | 2 | 0.0 |
Phosphoric Monoester Hydrolases/metabolism | 2 | 2.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
3T3 Cells | 4 | 0.0 |
Apoptosis/*drug effects | 2 | 0.0 |
Ligands | 3 | 0.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
*Proto-Oncogene Proteins | 11 | 0.0 |
*Gene Expression Regulation, Neoplastic | 6 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*physiology | 2 | 3.0 |
Proto-Oncogene Proteins/*physiology | 3 | 1.0 |
Adenocarcinoma/*genetics | 3 | 2.0 |
Glycogen Synthase Kinase 3 | 3 | 3.0 |
Glycogen Synthase Kinases | 2 | 3.0 |
Time Factors | 3 | 0.0 |
Cell Proliferation | 2 | 1.0 |
Glucose/metabolism | 3 | 1.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Sodium/metabolism | 2 | 1.0 |
Proto-Oncogene Proteins/*metabolism | 5 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Insulin/pharmacology | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Protein Biosynthesis | 3 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Protein-Serine-Threonine Kinases/chemistry/genetics/*metabolism | 2 | 4.0 |
Aged, 80 and over | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
*Oncogenes | 6 | 1.0 |
Ovarian Neoplasms/*genetics | 5 | 1.0 |
Genes, Dominant | 2 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Pedigree | 2 | 0.0 |
BRCA2 Protein | 2 | 0.0 |
Genes, ras | 2 | 0.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
Oncogene Proteins/genetics | 3 | 4.0 |
Protein-Serine-Threonine Kinases/genetics | 3 | 2.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Oncogene Proteins/*genetics | 4 | 2.0 |
Protein-Serine-Threonine Kinases/*genetics | 4 | 1.0 |
Prognosis | 3 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Mice, Nude | 2 | 0.0 |
Cell Division | 2 | 0.0 |
*Gene Amplification | 2 | 0.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 4 | 0.0 |
Caco-2 Cells | 2 | 0.0 |
Gene Library | 2 | 0.0 |
Breast Neoplasms/genetics/*pathology | 2 | 4.0 |
Adolescent | 2 | 0.0 |
Glutathione Transferase/metabolism | 3 | 0.0 |
Plasmids/metabolism | 4 | 0.0 |
Chemotherapy, Adjuvant | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Insulin/*metabolism | 2 | 2.0 |
